Back to top
more

The Cooper Companies (COO)

(Real Time Quote from BATS)

$69.77 USD

69.77
998,013

-1.68 (-2.35%)

Updated Aug 5, 2025 01:34 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (59 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

The Cooper Companies Inc (COO), based in Pleasanton, CA, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision (CVI) and CooperSurgical (CSI). CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company’s products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness. CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. This strategic business unit has pursued a strategy of consolidation by acquiring critical treatment niches in a fragmented market.

Zacks Equity Research

Here's Why You Should Retain Cooper Companies (COO) Now

by Zacks Equity Research

Investors remain optimistic about Cooper Companies (COO) backed by strong CSI and CVI product portfolios and its continued leadership in the specialty lenses market.

Trina Mukherjee headshot

3 Stocks to Capitalize on Promising Dental Supplies Industry

by Trina Mukherjee

Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

Zacks Equity Research

DENTSPLY SIRONA (XRAY) at a 52-Week High: What's Driving It?

by Zacks Equity Research

DENTSPLY SIRONA (XRAY) is optimistic about growth in CAD/CAM business arm along with its recent product launch and strategic buyouts.

Zacks Equity Research

Here's Why You Should Buy Align Technology (ALGN) Now

by Zacks Equity Research

Investors continue to be optimistic about Align Technology (ALGN) on robust international performance and continued portfolio expansion.

Zacks Equity Research

Cooper Companies (COO) Surges 4.5%: Is This an Indication of Further Gains?

by Zacks Equity Research

Cooper Companies (COO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

Cooper Companies (COO) Q1 Earnings & Revenues Top Estimates

by Zacks Equity Research

Cooper Companies' (COO) fiscal first-quarter earnings reflect solid segmental performance.

Zacks Equity Research

Cooper Cos. (COO) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Cooper Cos. (COO) delivered earnings and revenue surprises of 14.44% and 3.10%, respectively, for the quarter ended January 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Cooper Companies (COO) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Cooper Companies' (COO) fiscal first-quarter results are likely to reflect strength at MiSight 1-day contact lens.

Zacks Equity Research

What's in Store for Fulgent Genetics (FLGT) in Q4 Earnings?

by Zacks Equity Research

We expect strong demand for Fulgent Genetics' (FLGT) end-to-end tests for COVID-19 to have continued through the fourth quarter.

Urmimala Biswas headshot

4 Medical Products Stocks Set to Beat This Earnings Season

by Urmimala Biswas

Rebound in sales volumes and rise in COVID-19 support products sales make us optimistic about MDT, MASI, XRAY and COO's results.

Zacks Equity Research

Owens & Minor (OMI) to Report Q4 Earnings: What's in Store?

by Zacks Equity Research

We expect the strength in demand for Owens & Minor's (OMI) PPEs to have continued through the fourth quarter.

Zacks Equity Research

Lower Bulk Purchases May Weigh on Medtronic (MDT) Q3 Earnings

by Zacks Equity Research

Medtronic's (MDT) diabetes care, robotics surgery and neuromodulation lines are expected to have performed well in Q3.

Zacks Equity Research

Ecolab (ECL) to Report Q4 Earnings: What's in the Offing?

by Zacks Equity Research

Ecolab's (ECL) fourth-quarter results are likely to reflect gains from the Global Healthcare and Life Sciences segment.

Zacks Equity Research

OPKO Health (OPK) to Report Q4 Earnings: What's in Store?

by Zacks Equity Research

OPKO Health's (OPK) fourth-quarter results are likely to reflect solid performance from Services and Products segment and RAYALDEE.

Zacks Equity Research

Invitae (NVTA) to Report Q4 Earnings: What's in the Offing?

by Zacks Equity Research

Invitae's (NVTA) fourth-quarter results are likely to reflect strength in genetic testing.

Zacks Equity Research

Align (ALGN) Extends Invisalign G8 Availability Worldwide

by Zacks Equity Research

Align's (ALGN) latest evolution in biomechanics is set to improve treatment predictability for frequently treated case types.

Zacks Equity Research

Can Cooper Cos. (COO) Keep the Earnings Surprise Streak Alive?

by Zacks Equity Research

Cooper Cos. (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

The Cooper Companies (COO) Unit Gets a Boost From New Buyout

by Zacks Equity Research

The Cooper Companies (COO) arm's buyout drives its growing portfolio of medical products, which revolves around clinic and practice-based women's healthcare

Zacks Equity Research

Here's Why You Should Retain Cooper Companies (COO) Stock

by Zacks Equity Research

Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

Zacks Equity Research

Cooper Companies (COO) Q4 Earnings & Revenues Top Estimates

by Zacks Equity Research

Cooper Companies' (COO) fiscal fourth-quarter earnings reflect weak segmental performance. However, it exceeds expectation as it witnesses faster-than-anticipated recovery.

Zacks Equity Research

Cooper Cos. (COO) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Cooper Cos. (COO) delivered earnings and revenue surprises of 1.61% and 0.38%, respectively, for the quarter ended October 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Cooper Cos. (COO) Q4 Earnings Expected to Decline

by Zacks Equity Research

Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Cooper Companies (COO) to Post Q4 Earnings: What's in Store?

by Zacks Equity Research

Cooper Companies' (COO) fiscal fourth-quarter performance is likely to reflect better performance by CVI and CSI.

Zacks Equity Research

Here's Why You Should Invest in Cooper Companies (COO) Stock

by Zacks Equity Research

Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

Zacks Equity Research

PDCO vs. COO: Which Stock Is the Better Value Option?

by Zacks Equity Research

PDCO vs. COO: Which Stock Is the Better Value Option?